Health News

Research from the Northwestern University Feinberg School of Medicine has found that a less toxic, solvent-free chemotherapy drug more effectively prevents the progression of metastatic breast cancer and has fewer side effects than a commonly used solvent-based drug.

Read more

Filed under: Pharmacy News
Tags: Breast Cancer, cancer, Drug, medicine, Pharmacy

Related posts

• Sanofi-aventis announces publication of positive BSI-201 phase II results for breast cancer (0)
  Sanofi-aventis and its wholly-owned subsidiary, BiPar Sciences, today announced that The New England Journal of Medicine published the final phase II data for the investigational drug iniparib demonstrating significant clinical benefit in women with metastatic triple negative breast cancer when iniparib was administered in combination with chemotherapy agents gemcitabine/carboplatin. Read more [tags] Pharmacy News [/tags]
  
  
• Results In ‘The New England Journal Of Medicine’ Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery (0)
  Newly published data in The New England Journal of Medicine affirm five-year upfront use of Femara((R)) (letrozole tablets) following surgery as an optimal treatment approach versus tamoxifen for postmenopausal women with early stage breast cancer (hormone-receptor positive). Read more [tags] Pharmacy News [/tags]
  
  
• Positive Phase II Results With Iniparib (BSI-201) In Women With Metastatic Triple Negative Breast Cancer (0)
  Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and its wholly-owned subsidiary, BiPar Sciences, today announced that The New England Journal of Medicine (NEJM) published the final phase II data for the investigational drug iniparib* (BSI-201) demonstrating significant clinical benefit in women with metastatic triple negative breast cancer (mTNBC) when iniparib was administered in... Read more [tags] Pharmacy News [...]
  
  
• PINC trial to test anti-malarial drug in women with DCIS (0)
  Can a drug that has been used to treat malaria for years possibly be used to treat breast cancer before it becomes invasive? That's what researchers at George Mason University's Center for Applied Proteomics and Molecular Medicine (CAPMM) and Inova Breast Care Institute (IBCI) are trying to prove. Read more [tags] Pharmacy News [/tags]
  
  
• NSAIDs like ibuprofen slow the spread of breast cancers (0)
  Published online on Aug. 7, 2011, the journal Nature Medicine reports that non-steroidal anti-inflammatory drugs including ibuprofen reduce the severity of postpartum breast cancers in animal models. Read more [tags] Pharmacy News [/tags]